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Abstract: Hephaestin (Hp) is a trans-membrane protein, which plays a critical role in intestinal iron absorption. Hp was originally
identified as the gene responsible for the phenotype of sex-linked anaemia in the sla mouse. The mutation in the sla protein causes accumulation of dietary iron in duodenal cells, causing severe microcytic hypochromic anaemia. Although mucosal uptake of dietary iron
is normal, export from the duodenum is inhibited. Hp is homologous to ceruloplasmin (Cp), a member of the family of multi copper ferroxidases (MCFs) and possesses ferroxidase activity that facilitates iron release from the duodenum and load onto the serum iron transport protein transferrin. In the present study, attempts were made to produce biologically active recombinant mouse hephaestin as a
secretory form tagged with green fluorescent protein (GFP), Hpsec-GFP. Plasmid expressing Hpsec-GFP was constructed and transfected
into COS and CHO cells. The GFP aided the monitoring expression in real time to select the best conditions to maximise expression and
provided a tag for purifying and analysing Hpsec-GFP. The protein had detectable oxidase activity as shown by in-gel and solution-based
assays. The methods described here can provide the basis for further work to probe the interaction of hephaestin with other proteins
using complementary fluorescent tags on target proteins that would facilitate the fluorescence resonance energy transfer measurements,
for example with transferrin or colocalisation studies, and help to discover more about hephaestin works at the molecular level.
Key words: Hephaestin, ceruloplasmin, ferroxidase, iron

1. Introduction
Iron is an essential micronutrient required by every human
cell and has the capacity to accept and donate electrons
readily by interconverting between ferrous, depicted as
Fe(II), and ferric, depicted as Fe(III), forms. Hence, iron
is important for oxygen transport, energy transfer, and
nucleic acid biosynthesis. A normal adult man has 40–
50 mg iron/kg body weight (Andrews, 1999; WesslingResnick, 2000). Although only about 0.1%–0.2% of iron
(~7mg) is bound to transferrin (Tf) in extracellular fluids
for transit, the turnover of this transported pool is highly
dynamic, reaching 30–35 mg/day (Hirota, 2018; Sherwood
et al., 2018; Wessling-Resnick, 2000).
The molecular basis of dietary iron absorption into
the body is currently quite well understood. Dietary iron
is absorbed mainly in the duodenum, either as ferrous
iron transported across the apical membrane of the
enterocyte via divalent metal transporter-1 (DMT1), or as
heme iron transported possibly via the heme-responsive

gene HRG (Knutson, 2017) or HCP1 (Lawen and Lane,
2013). Once inside the enterocyte, the iron can be stored
or exported across the enterocyte basolateral membrane
by the ferrous iron exporter ferroportin (FPN) (Knutson,
2017). Hephaestin (Hp) increases the efficiency of this
process by oxidising the transported iron to its ferric form
and promoting its release from FPN (Crichton, 2009; Han,
2011; Lawen and Lane, 2013; Deshpande et al., 2017), from
which it is rapidly bound to apo-Tf for transport in the
circulation to tissues (Lawen and Lane, 2103; Knutson,
2017). In short, Hp plays a role in the uptake of iron from
the diet, whereas Cp helps with the redistribution of iron
to the cells and tissues; however, how Hp interacts with Tf,
Cp, and FPN is still unclear.
To understand this mechanism, iron metabolismdisordered animals, e.g., knockout (KO) mice and sla mice,
have been studied as useful models of iron homeostasis. By
studying sla mice, Hp was identified as a key component
of intestinal iron transport. Sla mice develop moderate to
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severe microcytic hypochromic anaemia due to a block in
intestinal iron transport—dietary iron is absorbed into the
enterocyte, but export into the circulation is compromised.
Hp has 50% sequence similarity with Cp, including the
conservation of multiple copper binding sites (Vulpe et
al., 1999; Griffiths et al., 2005) and is highly expressed in
sla mouse intestine. Interestingly, in sla mice, this gene
shows an in-frame deletion of 194 amino acids, probably
resulting in a non-functional product (Ranganathan et al.,
2012a; Deshpande et al., 2017). The researchers conclude
that this protein is a transmembrane-bound ferroxidase
that plays an important role in the iron export mechanism
involving FPN and Tf (Hudson et al., 2008; Vashchenko
and Macgillivray, 2012; Lee et al., 2012; Chen, 2018; Zheng
et al., 2018). The identification of mutant hephaestin as
the gene responsible for the sex-linked anaemia in sla
mice provides an important link between iron and copper
metabolism in mammals (Lieu et al., 2001).
However, recent investigations performed using
intestinal Hp knockout indicate that the link between Hp
activity and iron absorption is not simple (Doguer et al.,
2017).
In the current study, we have investigated the
recombinant Hpsec-GFP plasmid prior to transfection in
the COS cell system to study the expression of bioactive,
recombinant soluble hephaestin in COS and CHO cells
and then to assess its ferroxidase activity and iron efflux
ability.
In the current study, the main aim was to understand
and investigate the role of Hp systemic iron homeostasis
by studying the activity assays and expression studies.
Therefore, microscopy was used to study the
intracellular distribution of Hp and ascertain whether the
correct protein is expressed. The data for the recombinant
GFP-tagged Hp plasmids showed different patterns of
expression. Full-length Hp-GFP was also constructed to
confirm the localisation of Hp for further analysis, but the
data are not shown here.
2. Materials and methods
2.1. Construction of soluble hephaestin protein
The Hp cDNA from mouse was subcloned from pcDNA3.1
into pEGFP-N3 as an expression vector for the expression
of GFP-tagged proteins in eukaryotic cells to create GFPtagged soluble and full-length forms of hephaestin (2
separate subcloning works, full length and truncated).
For the soluble/secretory form of Hp devoid of the
transmembrane domain (TM), a C-terminus fragment
upstream of the TM domain was amplified using the primers
Heph5 (5’-TCTGCAGAAATGGTATCTTGGAACC-3’) and
Heph3A(5’-CCGAATTCAAGCGCTATCCTTTATGGGAA
TGTTCATGCCC-3’), including a stop codon introduced
just prior to the TM domain (Figure 1).
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2.2. PCR amplification
A 50 µL reaction was prepared by mixing on ice 200 nM
of each dNTP, 50 ng of template DNA, and 0.4 µM of each
primer in 1xVentRbuffer [20 mM Tris-HCl (pH 8.8), 10
mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton
X-100]. Fifty µL of mineral oil were layered on top, and
the reaction was subjected to a hot start treatment, i.e. the
above reaction mix was incubated for 3–5 minutes at 94
°C before the addition of 2 U of VentR polymerase (New
England Biolabs, Ipswich, MA, USA). Thermal cycling
parameters were as follows: DNA denaturation at 94 °C
for 1 min; primer annealing for 1 min at a temperature
range of 55–72 °C, which was determined empirically
for each template/primer pair; and primer extension at
72 °C, allowing 1 min per kilobase of expected extension
product. A total of 30 cycles were carried out, followed by
the incubation of the reaction at 72 °C for 10 min.
The PCR fragment was digested with HpaI and EcoRI
restriction enzymes and gel purified prior to subcloning
into the pcDNA3.1-Heph via HpaI and EcoRI sites (Figure
1) to create a cDNA, encoding a soluble/secretoryform
of Hp (Hpsec). The truncated Hp construct was then
subcloned into the Eco47III site of the pEGFP-N3 vector
via AflII (blunted) and Eco47III to generate a cDNA, which
expresses the recombinant Hpsec-GFP. The recombinants
with correct orientation were selected by digestion with
XhoI and the mutations were verified by sequencing.
2.3. Cloning and expression of the Hp protein
The bacterial cells INVαF’, JM109, and MC1061/P3,
and the cloning vectors pcDNAI and pcDNA3.1 were
purchased from Invitrogen (Paisley, UK). The pEGFPN3
was purchased from Clontech (Nottinghamshire, UK).
The pcDNA3.1 is a high level constitutive mammalian
expression vector. It has the hCMV promotor, which is
able to drive high levels of transcription in a wide variety
of mammalian cells (Foecking and Hofstetter, 1986). The
NovaBlue E. coli K12 strain and the pSTBlue-1 vector
were purchased from Novagen (Nottingham, UK).
The pSTBlue-1 is also a multipurpose bacterial cloning
and expression vector with versatile MCS, T7, and SP6
promoters and ampicillin and kanamycin resistance genes.
2.4. The COS cell system and passaging of cells
The COS-7 cells were obtained from the European
Collection of Animal Cell Cultures. The cells were
cultured in 9 cm disposable culture dishes in a moist
atmosphere of 95% air and 5% CO2 at 37 °C. The COS
cells were subcultured before confluency in the log phase
of growth. The spent medium was discarded, and the
monolayer of the cells was dislodged from the plate with
a solution of 1x trypsin at 37 °C for 10 min. The cells were
collected, sedimented, and the cell pellet was resuspended
in complete RPMI 1640. Fresh plates were seeded with
1
/10 volume of cell suspension and topped up with 9 mL of
fresh medium.
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2.5. Transfection using DEAE-Dextran
A day before the transfection, 3–5 x 105 cells per 9-cm
culture dish were seeded. For each 9-cm dish, a transfection
solution was prepared comprising 4.0 mL serum-free
RPMI 1640, containing 200 mg/mL DEAE-Dextran and
10 mg of plasmid DNA, and the pH was adjusted to 7.4
with 0.4 mL 0.5 M Tris-HCl. After 24 h, the cells were
washed 3 times with warmed serum-free RPMI 1640, and
4 mL of DEAE-Dextran-DNA mixture was added to each
dish. The cells were incubated at 37 °C for 4 h. They were
washed twice with serum-free RPMI 1640 and were then
exposed to a RPMI 1640 7% FCS (v/v) solution containing
100 mM chloroquine and incubated at 37 °C for 3 h.
Finally, the cells were washed twice, and cultured in full
RPMI 1640 for 48–72 h.
2.6. Transfection of mammalian cells by electroporation
The electroporation of the COS and CHO cells was carried
out using the preset protocol (160 V, 500 mF, exponential
decay) in the Gene Pulser Xcell electroporation system
(BioRad Laboratories, Inc., Philadelphia, PA, USA)
experimentally with the optimum results obtained. The
cells were pulsed once, immediately transferred to a culture
dish, and cultured. Transient gene expression was assessed
24–48 h following electroporation with a fluorescent
inverted microscope (Olympus 1X51, Olympus UK Ltd,
Middlesex, UK). The transfected cells were usually fixed
in 2% (w/v) paraformaldehyde in PBS for 1 h at room
temperature prior to observing GFP fluorescence. One day
after plating on coverslips, the GFP-tagged Hp constructs
were transfected into COS-7 and CHO. Then, the cells
were fixed in 2% (v/v) formaldehyde in PBS for 10 min.
The images were then collected using confocal microscopy
(Carl Zeiss Microscopy GmbH, Oberkochen, Germany).
2.7. Measurement of the hephaestin and Cp protein
oxidase activity assay
A) 0.1% o-dianisidine oxidase assay
The samples obtained from the cell culture were
subjected to PAGE (10% gel) under native conditions
(nondenaturing). After electrophoresis, the gel was briefly
rinsed in 0.1 M sodium phosphate buffer with ph 5.7. The
oxidase activity was assayed qualitatively by incubating
with the same buffer containing 0.1% o-dianisidine (3,
3´-Dimethoxybenzidine) and 30% ethanol at 37 °C for
60 min. The gel was left at room temperature until the
staining for oxidase activity was clearly visible.
B) p-phenylenediamine oxidase activity measurement
Serum ceruloplasmin p-phenylenediamine (PPD) oxidase
activity was measured. At ph 5.6, ceruloplasmin catalysed
the oxidation of ppd to yield a coloured product. The
0.45 M acetate buffer solution with ph 5.8 was prepared
as follows: 36.91 g of CH3COONa was dissolved in 1000
mL of deionized water. Reagent grade glacial acetic acid
(25.87 mL) was diluted to 1000 mL with deionized water

(final concentration, 0.45 M). The sodium acetate solution
(940 mL) was mixed with 60 mL of acetic acid solution
under a ph meter; the ph of the acetic acid-sodium acetate
buffer was 5.8. Then, 0.1 g p-phenylenediamine substrate
was dissolved in sodium acetate buffer, treated with
Chelex-100 by mixing by a rotator for 15–20 min, and
centrifuged for 3–5 min at 700 rpm to collect the Chelex
pellets to avoid interference in the assay. The buffer and
sample mixtures were warmed at 37 ° C before the substrate
was added at 1 min intervals. After this step, 10 μL (or 100
μL) aliquots of the sample in lysis buffer were assayed in a
total volume of 1.0 mL (or 10 mL). The absorbance of each
sample at 530 nm was measured using the CECIL 1021
Spectrophotometer at certain time intervals.
2.8. Western blotting
The proteins from SDS-PAGE were transferred to
HybondTM-C extra membrane and optimised for protein
transfer from Biosciences UK Ltd. (Amersham, UK) using
a wet Western blot system (Hoeffer) run at 100 ma for 1.5
h or 15 ma overnight. Following blocking with 1% (w/v)
skimmed milk powder (Marvel) in 0.05% (v/v) Tween-20,
TBS, the nitrocellulose was then incubated for 2 h with
either rabbit antimouse hephaestin (Alpha Diagnostic
International, Inc., San Antonio, TX, USA) or anti-GFP
antibody (Abcam Ltd., Cambridge, UK). All antisera were
diluted to 1:500 in TBS prior to use. The sheet was washed
3 × 5min with TBS [0.05% (v/v) Tween-20]. Following
the secondary antibody incubation, the membrane was
incubated with 4 μL of streptavidin-alkaline phosphatase
in 3 mL of 1% blocking buffer for 1 h in constant shaking
at room temperature. The membrane was then incubated
with freshly prepared substrate solution [60 μL of nitroblue tetrazolium (NBT) (Sigma-Aldrich Corp., St.
Louis, MO, USA), 60 μL of 5-bromo-4-chloro-3-indolyl
phosphate (BCIP), and 5 mL of alkaline phosphatase
buffer]. After the overnight incubation in darkness for
band development, the membrane was washed with
distilled water to quench the developing reaction.
2.9. Immunoprecipitation of recombinant hephaestin
Rabbit polyclonal anti-GFP antibody with a volume of
0.5 µL was added to 10 mL of cell medium (or lysate)
containing recombinant Hp and was incubated on ice for 1
h. Then, 50 µL washed Pansorbin (10% (v/v) in lysis buffer:
0.5% TX-100 in PBS) was added to the mixture and further
incubated for 1 h at 4 °C on a rocking platform. The beads
were pelleted by centrifugation at 10,000 g for 15 s at 4 °C,
the supernatant was removed by gentle aspiration, and the
immune complex was washed on the beads 3 times with
lysis buffer. Each time, 1 ml of lysis buffer was added and
the beads were resuspended by pipetting. Following this, 50
µL of 1 × SDS gel-loading buffer was added to the washed
pellet and the proteins were denatured by putting the tube
in boiling water for 5 min. The sample was centrifuged for
15 s at 10,000 g and the supernatant was loaded on the gel.
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3. Results
3.1. Expression of the recombinant Hpsec-GFP in the COS
cells
GFP-tagged soluble Hp was prepared for expression
studies (Figures 1 and 2). The Hpsec-GFP construct was

initially tested in a COS cell system. The COS cells were
chosen for transfection because of their convenience to
generate stable cell lines. Moreover, they provide a high
level of expression and are adherent cells and therefore
quite appropriate for microscopy studies. The intracellular

Figure 1. Plasmid construction for GFP-tagged secretory hephaestin. (A) The secretory form of
hephaestin (Hpsec-GFP) was constructed for expression studies. (i) The full-length hephaestin
cDNA was used as a template to amplify the 622 nt C-terminus fragment immediately upstream
of the transmembrane I domain. (ii) The PCR product was religated into the pcDNA3.1 vector
containing the N-terminal portion of hephaestin. Selected recombinants were sequenced
through the full-length of the PCR amplicon. (iii) The recombinant hephaestin was fused to
the N terminus of EGFP coding sequence. (B) The 3´ PCR primer was designed to include the
Eco47III, EcoRI sites for the ease of subcloning and a stop codon. The single letter amino acid
code is shown above the codons. The boxed region corresponds to the hephaestin sequence.

Figure 2. PCR products for generation of recombinant Hp constructs. 10 µL samples of PCR products were electrophoresed on a 1%
agarose gel for 1 h at 100 mA. Lanes 1 and 2 contain the amplicons of the C-terminus of the secretory hephaestin construct produced
using primers Heph5 and Heph3A described in Methods 2.1. Lane (M) is the 100 bp ladder (New England Biolabs). Lanes 3 and 4
contain amplicons of the C-terminus of the full-length (wild type) Hp with stop codon ablated.
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distribution of Hp was checked by fluorescence microscopy
and the expression profile of Hp was compared with
the control GFP expression system, which has a distinct
expression pattern (Figures 3 and 4).
Hpsec-GFP was transfected into the COS-7 cells using
DEAE-Dextran or lipofectamine TM reagents. Figure 3
shows the expression of these recombinant Hp molecules,
which is the expected expression pattern for the soluble
Hpsec-GFP construct. The pattern correlates well for a
secretory protein localisation with a strong perinuclear
expression, and a vesicular pattern of localisation
throughout the cytoplasm, suggesting that the protein
is likely to be secreted. Moreover, the expression profile
was distinct from GFP control construct (Figure 4), in
which staining was uniform throughout the cell, including
the nucleus. Taken together, the patterns of localisation
suggest that the construct is expressing chimeric HpsecGFP with the patterns of localisation broadly expected

for soluble protein. However, further experiments were
needed to confirm that the correct protein was being
expressed. Thus, the expression was further confirmed by
Western blotting and biological activity was assessed by
monitoring the oxidase activity.
3.2. Immunoprecipitation (IP) method for the
preparation of GFP-tagged soluble hephaestin and the
requirement of heating for elution
In this study, the recombinant soluble Hp protein was
analysed from the cell culture medium from transfected
CHO cells by using an anti-GFP antibody. The
immunoprecipitation technique was used to increase the
yield of proteins for the analysis. The expected size of the
protein was 150 kDa for Hpsec-GFP, based on the size of the
Hpsec and GFP polypeptides (Syed et al.,2002). Specific bands
were successfully detected from the immunoprecipitated
sample heated at the elution step, with molecular weight

Figure 3. Expression of Hpsec-GFP in COS cells. (i) A strong green fluorescent signal was detected in the perinuclear region as indicated
by the arrow in (B) with punctate signals throughout the cytoplasm, gradually decreasing in intensity, moving from the nucleus to the
plasma membrane in the A, B, C, and D. (ii) Fluorescent signals (A and D) were checked by phase contrast shown in the middle panels
(B and E); partial signal in C and F. Cells were transiently transfected using the DEAE-dextran method.
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of 175 kDa (Hpsec-GFP) (Figure 5, lane 5) on Western
blot analysis. Hpsec-GFP was expressed in the CHO cells,
which were cultured in the selection medium containing
G418. The CHO cells expressing Hpsec-GFP took around

14–16 days to reach t=70%–80% confluency. During the
culturing, the Hpsec-GFP expression was closely observed
by fluorescent microscope because the collection time of
the cell culture media was critical for the preparation of

Figure 4. Expression pattern of GFP protein. GFP shows a distinct pattern in which staining is
evident throughout the cell, inducing the nucleus and therefore are easy to compare with HpGFP constructs showing in A and B. Cells were transiently transfected with pEGFP-N3 using the
DEAE-dextran method.

Figure 5. Identification of the recombinant Hpsec-GFP protein from CHO cells by Western blot. The cell culture medium or extracts
were immunoprecipitated with rabbit anti-GFP antibody, incubated with Pansorbin and detected with the same antibody. The protein
samples were electrophoresed on a 10% gel blotted and analysed with anti-GFP antibody and the figure shows immunoprecipitated
samples prepared with heating at 90 °C for 5 min vs. those prepared without heating. Lane 1 contains broad range protein standard
(New England Biolabs); lane 2 represents a negative control, immunoprecipitation of medium; lanes 3 shows a negative control,
immunoprecipitated medium from untransfected CHO cells; lanes 4 and 5 are Hpsec-GFP prepared from transfected medium which
gave a correct band for the sample eluted by heating (lane 5) at the end of precipitation, around 175 kDa indicated by arrow, but only
a faint band for the sample prepared from the same medium but without heating (lane 4). Lanes 6 and 7 show immunoprecipitates
prepared Hpsec-GFP cell extract, no band for the unheated samples of soluble hephaestin; lane 8 represents positive control, transfected
IRP1-GFP which is around 125 kDa. The figure shows that the heating was necessary to elute the protein.
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the sample. Therefore, cell culture studies were strictly and
carefully followed. The cell culture media were collected
from 3 plates, making the total volume between 30–50 mL
(9-cm dish), and then the immunoprecipitation technique
was carried out. An important part of the technique was
the elution step, which was performed by heating the
Pansorbin carrying the immunoprecipitates at 90 °C for
4–5 min. Although heating elution was potentially very
risky for the protein, the Hpsec-GFP prepared by heating
yielded effective results.
Specific bands were also successfully detected from
immunoprecipitates prepared from the transfected COS
cells, also with a molecular weight of 175 kDa (HpsecGFP) (Figure 6). The expected size of the recombinant
polypeptide for the Hpsec-GFP polypeptide was 150 kDa
(Syed et al., 2002). The difference between the predicted
polypeptide size and the actual size of the recombinant
product could be due to glycosylation, which will be
further confirmed. Once again, the bands were observed
when immunoprecipitates were eluted with heating
(Figure 6, lanes 2 and 3). One set of COS cells were treated
with 20 µM CuSO4 to see whether the yield of Hpsec-GFP
would be increased (Figure 6, lane 3). However, there
was no observable difference compared with Hpsec-GFP
prepared from untreated cells (Figure 6, lane 2).

3.3. Oxidase activity of the recombinant hephaestin
Having established that Hpsec-GFP can be successfully
expressed, oxidase activity was assessed by the method
of Johnson et al. (1967). Hpsec-GFP was purified from
the medium using immunoprecipitation with a rabbit
polyclonal antibody directed against GFP. The extracted
protein was run on a native gel and oxidase activity
was assayed using α-phenylenediamine/o- dianisidine
substrate. Purified human Cp was used as a positive
control. In the first experiments, the immunoprecipitates
were compared for oxidase activity and protein content
following electrophoresis of duplicate samples on the
same gel (Figure 7). A single band of oxidase activity is
evident (Figure 7A), which has the same mobility as a
single band of protein identified by Coomassie staining
(Figure 7B). The same preparations were analysed for
oxidase activity (Figure 8A) and for Hpsec-GFP expression
by Western blotting (Figure 8B). Cp was used to compare
oxidase activity (Figure 8A, lane 1) in the nondenaturing
gel and had a faster mobility than Hpsec-GFP (Figure 8A,
lane 2). The Hpsec-GFP prep gave a single band of 175
kDa on Western blotting (Figure 8B). Similarly, the HpsecGFP expressed from the COS cells also had a measurable
oxidase activity (Figure 9). Taken together, these data
demonstrate that Hpsec-GFP has oxidase activity and that

Figure 6. Western blot analysis of the hephaestin-GFPs expressed from COS cells. The cell culture medium or cell extracts were
immunoprecipitated with rabbit anti-GFP antibody, incubated with Pansorbin and detected with the same antibody. The protein
samples were electophoresed on a 10% SDS gel. Lane M contains broad range protein standards (New England Biolabs); lanes 2 and 3 are
immunoprecipitates of medium from cells, transfected with pHpsec-GFP treated without and with Cu2+ respectively, eluted with heating;
lane 4 represents a negative control, the immunoprecipitate of untransfected COS cell medium; lane 5 represents cellular extracts of
untransfected COS cells (negative control); lanes 6 and 7 are extracts of Hpsec-GFP transfected cells treated without and with Cu2+
respectively. Recombinant soluble hephaestin could be detected in immunoprecipitates of cell culture medium, but not of cell lysates.
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Figure 7. Coomassie staining and Oxidase activity of hephaestin expressed from CHO cells.
10% PAGE under nondenaturing conditions was used to separate the Hpsec-GFP expressed
from CHO cells in the medium. Duplicates of Hpsec-GFP samples were loaded. After
electrophoresis, the gel was cut in half and treated differently according to the protocols.
Bands were identified with coomassie staining and oxidase assay on nondenaturing gel. (A)
Oxidase staining was performed with o-dionisidine for the oxidase activity. Lane 1 contains an
immunoprecipitated of Hpsec-GFP. (B) Coomassie staining was performed for 1 h in staining
solution prior to overnight incubation in destaining solution; lanes 2 and 3 contain the
secretory hephaestin purified by immunoprecipitation from transfected medium expressed
in CHO cells; lanes 4 contain extract of CHO cells expressing full-length hephaestin and lanes
5 contains dialysed histidine tagged hephaestin. Western blot analysis confirms presence of
single band of 175 kDa and oxidase activity was detected for the Hpsec-GFP sample from the
same preparation (Figure 8).

Figure 8. Gel oxidase assay and western blotting of hephaestin expressed from CHO cells. 10% PAGE under nondenaturing conditions
was used to separate the Hpsec-GFP expressed from CHO cells in the medium. After electrophoresis, the gel was cut in half and treated
differently for oxidase assay and Western blotting analysis for the same set of samples. Bands were confirmed to be hephaestin both
with oxidase staining and by western blotting on native on nondenaturing gel. (A) Oxidase staining was performed with o-dionisidine
for the oxidase activity. Lane 1 contains 5 µg of ceruloplasmin (Cp) as positive control; lane 2 represents the secretory hephaestin
purified by immunoprecipitation from transfected medium expressed in CHO cells. (B) Western blot analysis of immunoprecipitated
Hpsec-GFP expressed from CHO cells. Lane M contains broad range protein standards (New England Biolabs); lane 2 represents an
immunoprecipitated pHpsec-GFP from CHO cells and lane 3 shows the immunoprecipitate of untransfected CHO cell medium. The
arrows indicate the bands of Hpsec-GFP from either gel, which had the same mobility.
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Figure 9. Oxidase activity of hephaestin expressed from COS cells. 10% PAGE under nondenaturing conditions was used to separate the Hpsec-GFP expressed from COS-7 cells in the
medium. Lanes 1 and 2 contain 5 µg of ceruloplasmin (Cp) as positive control, and lanes 3 and
4 contain the secretory hephaestin purified by immunoprecipitation from transfected medium
expressed in COS-7 cells. Staining was performed with o-dionisidine for the oxidase activity.

the recombinant protein has folded successfully even
though it is a secretory form.
3.4. The measurement of solution-based oxidase
activityor p-phenylenediamine oxidase activity
Having established that the recombinant Hpsec-GFP
had oxidase activity, it was of interest to use a solutionbased oxidase assay to obtain quantitative data. Stably
transfected CHO cells were used to express Hpsec-GFP.
The expressed Hpsec-GFP was obtained 14–16 days after
the transfection and the expression level was checked by
fluorescence microscopy 3 times a week. Each time, fresh
medium containing G418 was added. When the HpsecGFP cells reached an expression level of 70%–80%,the cell
medium was collected from 3 or more plates. The samples
were prepared by immunoprecipitation from a total of 50
mL cell medium and the samples were eluted by heating at
90 °C for 4–5 min.
Oxidase activity was assayed by the method of Sato and
Gitlin (1991). The Hpsec-GFP oxidase activity was assayed
using α-phenylenediamine substrate. Protein was assayed
by the Bradford method and the equivalent amounts were
assayed per experiment, typically about 5 µg protein.
Oxidase activity could be detected in immunoprecipitates
from the medium of cells expressing Hpsec-GFP. Figure 10
shows data from one set of assays.
In this experiment, the effect of elution by heating
was analysed by preparing the immunoprecipitates with

and without heating on the final stage of protein elution.
As seen on the graph (Figure 10A), heating is necessary
to elute activity after immunoprecipitation. The samples
were stored at 4 ºC for 10 days and reassayed. Figure 10B
shows that oxidase activity was lost over this period, and
that freshly prepared samples had to be used shortly after
preparation for oxidase studies.
3.5. The effect of copper on the expression and activity of
the hephaestin protein
The availability of copper in the system may also
contribute to the levels of expressed hephaestin. In order
to address this concern, 20 µM Cu2+was supplemented to
the medium to try to increase the yield of proteins. Further
addition of copper did not seem to increase the levels of
expression. The possible reason could be the toxic effect of
copper on cells because the survival times of cells treated
with Cu2+were shorter than cells without extra Cu2+.
In this experiment, the cells were treated with/out
copper to investigate the requirement of copper for
oxidase activity. Stably transfected CHO cells expressing
Hpsec-GFP had a slight increase in oxidase activity when
treated with copper, compared with untreated samples,
but on Western blots, no band was detected from either
treated or untreated samples. Even though a slightly
increased oxidase activity was found, the cells treated
with copper were less viable and protein yields were low.
Future work is needed to investigate the effect of copper
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of lower concentrations to find the optimal concentration
to increase yield without affecting cell growth (Figure 11).
4. Discussion
In recent years, a number of key proteins involved in
iron metabolism have been identified, although this
information has not necessarily clarified certain aspects
of cellular iron metabolism. Hp was identified as a key
component of intestinal iron transport through the study
of sla mice (Vulpe et al., 1999; Ranganathan et al., 2012a).
The expression construct for Hpsec-GFP (Figures 1 and
2) produces a protein which is analogous to Cp, a soluble
serum protein produced in the liver. On microscopy,
the secretory form of Hp gave a strong green fluorescent
signal in the perinuclear region with punctuate signals in
the cytoplasm, gradually decreasing in intensity, moving
from the nucleus to the plasma membrane (Figures 3
and 4). The expression profile of Hp is distinct among
the molecules involved the iron metabolism pathway. In
our results, this profile is consistent with the expression
expected for soluble proteins (Shen et al., 2005).

The COS cell and CHO expression systems used in
this study produced usefully measurable amounts of
the recombinant Hpsec-GFP protein, as was confirmed
by Western blotting of immunoprecipitates from the
transfected COS and CHO cell media (Figures 5 and 6). The
expected size of protein was 150 kDa for Hpsec-GFP (Syed
et al., 2002) and specific bands were successfully detected
from immunoprecipitates with a molecular weight of 175
kDa according to Western blot analysis. Glycosylation
was expected to account for the difference between the
recombinant products with a predicted polypeptide size of
150 kDa and the actual size of 175 kDa.
In an attempt to confirm this expectation, the set of
samples was treated with Endo H enzyme to remove the
carbohydrate chains. However, this treatment did not
result in a change in the product size, possibly indicating
that sugar moiety was resistant to this enzyme.
Through the use of in-gel assays with an o-oxylamine
or phenylenediamine substrate, the Hpsec-GFP protein was
shown to possess oxidase activity (Figures 7–9). During the
current study, several experiments showed that heating was

Figure 10. Oxidase assay of recombinant Hpsec-GFP for heated and unheated samples. (A) Oxidase activity of heated soluble hephaestin
expressed in CHO cells. The active samples have about 30% activity above the negative controls. Immunoprecipitated protein eluted
with heating on the final stage of preparation has more activity than unheated precipitates. As seen on the graph Hpsec-GFP (unheated),
so heating is necessary to elute activity after immunoprecipitation. (B) Oxidase assay of recombinant Hpsec-GFP for heated and unheated
samples after 10 days storage at 4 °C: Immunoprecipitated medium of Hpsec-GFP sample with heating on the final stage of protein elution
are orange and Hpsec-GFP without heating are green which were assayed after 10 days; blues represent CHO and control; pink are the
medium as negative control. Oxidase activity of the soluble hephaestin samples were assayed after 10 days showed less activity than
freshly assayed ones (see Figures 10A and 10B). Data are the means of duplicates and are single experiments representative of three
batches. Error bars are omitted for clarity and standard deviations were less than 15% of the mean.
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Figure 11. Oxidase assay showing activity of soluble hephaestin expressed from cells with
and without copper treatment. Oxidase activity of soluble hephaestin expressed in CHO cells
treated with/out Cu+. Cells treated with 20 µM copper are in dark red; cells without copper
treatment are orange. Cu+ treated cells showed more activity than cells without Cu+ treatment,
but there were no significant differences on repeated assays (data not shown here). Data are
the means of duplicates and are single experiments representative of three batches. Error bars
are omitted for clarity and standard deviations were less than 15% of the mean.

necessary for the elution step of the immunoprecipitation;
the samples without heating did not yield any protein
and activity (Figures 5 and 10). Although the elution of
a protein by heating is risky, the Hp samples prepared by
heating did not denature. Attempts were made to assay the
oxidase activity of the immunoprecipitates still bound to
Pansorbin cells, but they were not accurate. As such, it was
not possible to measure how much oxidase activity may
have been lost by the heat treatment (Figure 10). Its ability
to withstand heat treatment shows that Hp has a stable
structure, but this may be because GFP helps stabilise the
protein. These results indicate that the recombinant protein
folds properly and has copper correctly incorporated into
it in order for it to have biological activity.
Interestingly, Kuo et al. (2004) demonstrated the
presence of detectable oxidase activity for the truncated
protein in sla mice, suggesting the possibility that other
factors may also contribute to the decreased iron exit in
sla mice. Indeed, it was also reported that the Hp protein
is mislocalised in sla enterocytes. It has been suggested
that the Hp ferroxidase activity may be necessary for the
effective release of iron from enterocytes, with or without
FPN interaction, in order to transport iron across the
basolateral membrane (Vulpe et al., 1999). The exact
role of Hp in the efflux process therefore still remains
unknown, but it is important to note that the possible sites
for Hp action might be on the basolateral surface with the
C-terminus in the cytoplasm, or in a vesicle (Syed et al.,
2002; Ranganathan et al., 2012b).

As noted above, Hp is a copper-containing protein
homologous to Cp, and its ferroxidase activity may aid the
binding of iron to apotransferrin since only Fe(III) binds
(Linder et al., 2003). Interestingly, according to Chen et
al. (2006), copper is likely not necessary for the proper
folding or assembly of most copper proteins, including
the multicopper oxidases. Furthermore, it does not
dramatically alter their subsequent stability (Chen et al.,
2006). Genetic or nutritional copper deficiency does not
change the levels of inactive apo-Cp, although the protein
has a decreased plasma half-life. In contrast, the finding
that copper deficiency decreased the Hp protein levels
suggests an unexpected and unusual link between copper
availability and protein stability (Figure 11).
The availability of copper in the system may contribute
to the levels of expressed Hp. Further studies are needed to
determine whether copper has a role in Hp expression and
whether the protein level and oxidase activity are reflective
of a copper-related process. To address this concern, an
additional 20 µM Cu2+ was added to the medium to try to
increase the yield of proteins in the system. This addition
of copper did not increase the levels of expression. The
possible reason is that the addition of a higher concentration
of copper or a nonoptimal concentration of copper to
the cells could exert toxic effects on cells. Although the
copper-treated cells had some oxidase activity, no band
was detected on Western blotting analysis; therefore, only
this single dose was applied during this analysis (Figure
11).
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According to the literature, intestinal iron transport
pathways are also Cu sensitive. It has been suggested that
copper deficiency chronically impairs Hp activity, which
leads to inefficient basolateral intestinal iron export, as
evidenced by increased enterocyte ferritin levels and
systemic iron deficiency and anaemia. It was found that
copper deficiency does not affect Hp transcript levels in
HT29 cells but results in dramatic decreases in Hp protein
and PPD oxidase activity. Together, these studies provide
evidence that copper deficiency does not change mRNA
levels but decreases Hp protein levels and subsequently
oxidase activity. The mechanisms of copper loading into
copper proteins in the secretory pathway are not known
and need to be clarified (Chen et al., 2006).

the protein. We were able to demonstrate a measurable
oxidase activity of the recombinant protein. We also
demonstrated that heating the immunoprecipitates
prepared using Pansorbin to 90 °C was necessary to free
Hp for analysis. Despite the high temperature used, Hp
had a demonstrable oxidase activity, suggesting that
the recombinant protein was very stable. The methods
described here provide a versatile means of producing
recombinant Hp under conditions that can be easily
achieved. In particular, the preparation of a secretory form
of tagged fluorescent hephaestin may allow further studies
to probe its interaction with transferrin, for example by
fluorescence resonance energy transfer.

5. Conclusion
In summary, we were able to produce a recombinant
secretory form of Hp tagged with GFP. The GFP tag was
helpful for monitoring the expression levels in real time,
helping to optimize conditions for the maximal expression
and also providing a tag for purifying and analysing
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